Detailed answers about ROCK POOL CLINICAL RESEARCH CONSULTING LIMITED, including incorporation, status, business activity, and accounts information.
When was ROCK POOL CLINICAL RESEARCH CONSULTING LIMITED founded?
ROCK POOL CLINICAL RESEARCH CONSULTING LIMITED was officially incorporated on 14 November 2024 and is registered under company number 16079378. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is ROCK POOL CLINICAL RESEARCH CONSULTING LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of ROCK POOL CLINICAL RESEARCH CONSULTING LIMITED?
ROCK POOL CLINICAL RESEARCH CONSULTING LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does ROCK POOL CLINICAL RESEARCH CONSULTING LIMITED do?
ROCK POOL CLINICAL RESEARCH CONSULTING LIMITED operates in the following sector: 72110 - Research and experimental development on biotechnology. This provides insight into the company's primary business activity and industry focus.
What is ROCK POOL CLINICAL RESEARCH CONSULTING LIMITED's registered address?
The registered office address of ROCK POOL CLINICAL RESEARCH CONSULTING LIMITED is 13A BELVOIR RD, EAST DULWICH, GREATER LONDON, UNITED KINGDOM, SE22 0QY. This is the official address filed with Companies House for legal and statutory correspondence.
Is ROCK POOL CLINICAL RESEARCH CONSULTING LIMITED financially stable?
Financial accounts for ROCK POOL CLINICAL RESEARCH CONSULTING LIMITED are not currently available. Without filed accounts, it is more difficult to assess the company's financial stability and trading performance.